Haffty Consulting Entering MEDITECH Consulting Market

Founding Owner/Partner David Haffty is excited to formally announce the launch of a new healthcare consulting and staffing company, Haffty Consulting. Joining David as co-founding Partners and forming the leadership team of Haffty Consulting are Shelly Noyes and David LaFontaine. David, Shelly, and David bring years of experience working together as a leadership team delivering similar services and solutions as part of a prominent healthcare consulting firm.

In discussing the driver behind forming Haffty Consulting, David LaFontaine shares that “consistent with our MEDITECH consulting “roots” and past experiences, Haffty Consulting will exclusively serve MEDITECH EHR customers.  Our focused, simple, and straightforward approach to doing business provides a refreshing alternative to current consulting options available to MEDITECH customers. Our singular focus will be on accelerating the value of the MEDITECH EHR.” 

Why Haffty Consulting?  We are building our team of consultants with the top talent in the market today, leveraging our collective decades of experience and relationships in the MEDITECH community.  We will always prioritize our client relationships and make decisions based on our collective best interests and long-term success not on short term considerations.  We have no outside investors, no conflicting interests at play.

Please visit our website, hafftyconsulting.com, to find out more about Haffty Consulting, our story, our services, and our differentiators.  We would be honored to be considered for your next MEDITECH-related consulting or staffing need(s).

We can be reached at info@haffyconsulting.com and would welcome the opportunity to speak with you, answer any questions you may have – but more importantly, to learn more about you, your organization, your ongoing needs, challenges, and opportunities regarding your MEDITECH EHR in 2023 and beyond.

Previous
Previous

Complimentary Denials Desktop Consultation

Next
Next

See you at MUSE 2023.